Suppr超能文献

细胞因子在 HIV 储存库的建立、持续和清除中的作用。

The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.

机构信息

VGTI Florida, Port St. Lucie, FL, USA.

出版信息

Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):143-9. doi: 10.1016/j.cytogfr.2012.05.001. Epub 2012 Jun 27.

Abstract

HIV persists in cellular and anatomical reservoirs during Highly Active Antiretroviral Therapy (HAART). In vitro studies as well as in vivo observations have identified cytokines as important factors regulating the immunological and virological mechanisms involved in HIV persistence. Immunosuppressive cytokines might contribute to the establishment of viral latency by dampening T cell activation and HIV production, thereby creating the necessary immuno-virological condition for the establishment of a pool of latently infected cells. Other cytokines that are involved in the maintenance of memory CD4(+) T cells promote the persistence of these cells during HAART. Conversely, proinflammatory cytokines may favor HIV persistence by exacerbating low levels of ongoing viral replication in lymphoid tissues even after prolonged therapy. The ability of several cytokines to interfere with the molecular mechanisms responsible for HIV latency makes them attractive candidates for therapeutic strategies aimed at reducing the pool of latently infected cells. In this article, we review the role of cytokines in HIV persistence during HAART and discuss their role as potential eradicating agents.

摘要

在高效抗逆转录病毒治疗(HAART)期间,HIV 存在于细胞和解剖学储库中。体外研究以及体内观察已经确定细胞因子是调节 HIV 持续存在所涉及的免疫和病毒学机制的重要因素。免疫抑制细胞因子可能通过抑制 T 细胞激活和 HIV 产生来促成病毒潜伏的建立,从而为潜伏感染细胞池的建立创造必要的免疫病毒学条件。其他参与记忆 CD4(+) T 细胞维持的细胞因子促进这些细胞在 HAART 期间的持续存在。相反,促炎细胞因子可能通过加剧淋巴组织中持续存在的低水平病毒复制,即使在长期治疗后,也有利于 HIV 的持续存在。几种细胞因子干扰 HIV 潜伏相关分子机制的能力使它们成为旨在减少潜伏感染细胞池的治疗策略的有吸引力的候选物。在本文中,我们综述了细胞因子在 HAART 期间 HIV 持续存在中的作用,并讨论了它们作为潜在清除剂的作用。

相似文献

1
The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.
Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):143-9. doi: 10.1016/j.cytogfr.2012.05.001. Epub 2012 Jun 27.
2
The challenge of viral reservoirs in HIV-1 infection.
Annu Rev Med. 2002;53:557-93. doi: 10.1146/annurev.med.53.082901.104024.
4
Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.
PLoS Pathog. 2007 Aug 31;3(8):e122. doi: 10.1371/journal.ppat.0030122.
5
The development of immune-modulating compounds to disrupt HIV latency.
Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):159-72. doi: 10.1016/j.cytogfr.2012.05.003. Epub 2012 Jul 4.
6
Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS.
J Virol. 2010 Mar;84(6):2913-22. doi: 10.1128/JVI.02356-09. Epub 2009 Dec 23.
7
Latently infected cell activation: a way to reduce the size of the HIV reservoir?
Bull Math Biol. 2012 Jul;74(7):1651-72. doi: 10.1007/s11538-012-9729-x. Epub 2012 May 5.
10
The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.
Front Immunol. 2021 Aug 31;12:720697. doi: 10.3389/fimmu.2021.720697. eCollection 2021.

引用本文的文献

1
Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size.
Int J Mol Sci. 2025 Aug 29;26(17):8430. doi: 10.3390/ijms26178430.
2
3
Intact HIV DNA decays in children with and without complete viral load suppression.
PLoS Pathog. 2025 Apr 4;21(4):e1013003. doi: 10.1371/journal.ppat.1013003. eCollection 2025 Apr.
6
Longitudinal patterns of inflammatory mediators after acute HIV infection correlate to intact and total reservoir.
Front Immunol. 2024 Jan 5;14:1337316. doi: 10.3389/fimmu.2023.1337316. eCollection 2023.
7
Interactions between microbiota and cervical epithelial, immune, and mucus barrier.
Front Cell Infect Microbiol. 2023 Feb 24;13:1124591. doi: 10.3389/fcimb.2023.1124591. eCollection 2023.
8
The Many Faces of Immune Activation in HIV-1 Infection: A Multifactorial Interconnection.
Biomedicines. 2023 Jan 8;11(1):159. doi: 10.3390/biomedicines11010159.
9
Synthetic Mucin Gels with Self-Healing Properties Augment Lubricity and Inhibit HIV-1 and HSV-2 Transmission.
Adv Sci (Weinh). 2022 Nov;9(32):e2203898. doi: 10.1002/advs.202203898. Epub 2022 Sep 14.

本文引用的文献

3
Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.
Immunity. 2012 Mar 23;36(3):491-501. doi: 10.1016/j.immuni.2012.01.014. Epub 2012 Mar 8.
4
Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.
J Clin Invest. 2012 Jan;122(1):62-9. doi: 10.1172/JCI59011. Epub 2011 Dec 12.
6
Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells.
PLoS Pathog. 2011 Oct;7(10):e1002288. doi: 10.1371/journal.ppat.1002288. Epub 2011 Oct 6.
8
The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point?
PLoS Pathog. 2011 Aug;7(8):e1002055. doi: 10.1371/journal.ppat.1002055. Epub 2011 Aug 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验